Xidiwei announced that the company originally intended to issue shares and pay cash to purchase 100% of Chengxinwei's shares and raise supporting capital. The transaction commenced in November 2024. During this period, trading of the company's shares was suspended from the opening of the market on November 5, 2024, trading resumed on November 18, 2024, the transaction review was suspended on September 30, 2025, and the review resumed on November 28. Based on considerations such as protecting the interests of the company and investors, the company decided to adjust the plan on December 31, 2025 and instead acquire 100% of Chengxin's shares in cash, which no longer involves issuing shares and raising supporting capital. This adjustment was approved by the board of directors and a special meeting of independent directors, and the company promised not to plan major asset restructuring within 1 month.

Xidiwei announced that the company originally intended to issue shares and pay cash to purchase 100% of Chengxinwei's shares and raise supporting capital. The transaction commenced in November 2024. During this period, trading of the company's shares was suspended from the opening of the market on November 5, 2024, trading resumed on November 18, 2024, the transaction review was suspended on September 30, 2025, and the review resumed on November 28. Based on considerations such as protecting the interests of the company and investors, the company decided to adjust the plan on December 31, 2025 and instead acquire 100% of Chengxin's shares in cash, which no longer involves issuing shares and raising supporting capital. This adjustment was approved by the board of directors and a special meeting of independent directors, and the company promised not to plan major asset restructuring within 1 month.